ArticleInternational journal of clinical oncology2026
Combination of baseline and first-week neutrophil-to-lymphocyte ratio predicts overall survival in advanced renal cell carcinoma treated with first-line combination immunotherapy.
Takeshi Sasaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.